2,784 research outputs found
Fraction-variant beam orientation optimization for non-coplanar IMRT
Conventional beam orientation optimization (BOO) algorithms for IMRT assume
that the same set of beam angles is used for all treatment fractions. In this
paper we present a BOO formulation based on group sparsity that simultaneously
optimizes non-coplanar beam angles for all fractions, yielding a
fraction-variant (FV) treatment plan. Beam angles are selected by solving a
multi-fraction FMO problem involving 500-700 candidate beams per fraction, with
an additional group sparsity term that encourages most candidate beams to be
inactive. The optimization problem is solved using the Fast Iterative
Shrinkage-Thresholding Algorithm. Our FV BOO algorithm is used to create
non-coplanar, five-fraction treatment plans for prostate and lung cases, as
well as a non-coplanar 30-fraction plan for a head and neck case. A homogeneous
PTV dose coverage is maintained in all fractions. The treatment plans are
compared with fraction-invariant plans that use a fixed set of beam angles for
all fractions. The FV plans reduced mean and max OAR dose on average by 3.3%
and 3.7% of the prescription dose, respectively. Notably, mean OAR dose was
reduced by 14.3% of prescription dose (rectum), 11.6% (penile bulb), 10.7%
(seminal vesicle), 5.5% (right femur), 3.5% (bladder), 4.0% (normal left lung),
15.5% (cochleas), and 5.2% (chiasm). Max OAR dose was reduced by 14.9% of
prescription dose (right femur), 8.2% (penile bulb), 12.7% (prox. bronchus),
4.1% (normal left lung), 15.2% (cochleas), 10.1% (orbits), 9.1% (chiasm), 8.7%
(brainstem), and 7.1% (parotids). Meanwhile, PTV homogeneity defined as D95/D5
improved from .95 to .98 (prostate case) and from .94 to .97 (lung case), and
remained constant for the head and neck case. Moreover, the FV plans are
dosimetrically similar to conventional plans that use twice as many beams per
fraction. Thus, FV BOO offers the potential to reduce delivery time for
non-coplanar IMRT
Recommended from our members
Viability of Non-Coplanar VMAT for Liver SBRT as Compared to Coplanar VMAT and Beam Orientation Optimized 4π IMRT.
PurposeThe 4π static non-coplanar radiotherapy delivery technique has demonstrated better normal tissue sparing and dose conformity than the clinically used volumetric modulated arc therapy (VMAT). It is unclear whether this is a fundamental limitation of VMAT delivery or the coplanar nature of its typical clinical plans. The dosimetry and the limits of normal tissue toxicity constrained dose escalation of coplanar VMAT, non-coplanar VMAT and 4π radiotherapy are quantified in this study.Methods and materialsClinical stereotactic body radiation therapy plans for 20 liver patients receiving 30-60 Gy using coplanar VMAT (cVMAT) were re-planned using 3-4 partial non-coplanar arcs (nVMAT) and 4π with 20 intensity-modulated non-coplanar fields. The conformity number (CN), homogeneity index (HI), 50% dose spillage volume (R50), normal liver volume receiving >15 Gy (VL>15), dose to organs at risk (OARs), and tumor control probability (TCP) were compared for all three treatment plans. The maximum tolerable dose (MTD) yielding a normal liver normal tissue control probability (NTCP) below 1%, 5%, and 10% was calculated with the Lyman-Kutcher-Burman model for each plan, as well as the resulting survival fractions at one, two, three, and four years.ResultsCompared to cVMAT, the nVMAT and 4π plans reduced VL>15 by an average of 5 cm3 and 80 cm3, respectively. 4π reduced the 50% dose spillage volume by ~23% compared to both VMAT plans, and either significantly decreased or maintained OAR doses. The 4π MTDs and survival fractions were significantly higher than both cVMAT and nVMAT (p<0.05) for all normal liver NTCP limits used in this study.ConclusionsThe 4π technique provides significantly better OAR sparing than both cVMAT and vMAT and enables more clinically relevant dose escalation for tumor local control. Therefore, despite the current accessibility of nVMAT, it is not a viable alternative to 4π for liver SBRT
(4RS)-Methyl 4-cyano-4-cyclohexyl-4-phenylbutanoate
In the crystal structure of the title compound, C18H23NO2, there are only van der Waals interactions present. The cyclohexyl ring has a chair conformation. The longer axes of the displacement parameters of the non-H atoms forming the ethylmethylcarboxylate skeleton are perpendicular to the plane through the non-H atoms of this skeleton
Efficient Concentration Protocols for the Single-Photon Entanglement State with Polarization Feature
We propose two efficient entanglement concentration protocols (ECPs) for arbitrary less-entangled single-photon entanglement state, in which the photon qubit has the polarization feature. The first ECP is in linear optics, and the second ECP is in nonlinear optics. The two ECPs have some attractive advantages. First, they can preserve the polarization feature of the photon qubit, while all the other existing ECPs for single photon state cannot achieve this goal. Second, they only require one pair of less-entangled single-photon entanglement state and some auxiliary single photons. Third, they only require local operations. Especially, the second ECP can be used repeatedly, which can increase its success probability largely. Based on above properties, our two ECPs, especially the second one may be useful in current and future quantum communication
Nuciferine downregulates Per-Arnt-Sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in HepG2 cells
Nonalcoholic fatty liver disease (NAFLD) is a prevalent liver disease associated with lipotoxicity, lipid peroxidation, oxidative stress and inflammation. Nuciferine, an active ingredient extracted from the natural lotus leaf, has been reported to be effective for the prevention and treatment of NAFLD. Per-Arnt-Sim kinase (PASK) is a nutrient responsive protein kinase that regulates lipid and glucose metabolism, mitochondrial respiration and gene expression. The aim of the present study was to investigate the protective effect of nuciferine against NAFLD and its inhibitory effect on PASK, exploring the possible underlying mechanism of nuciferine-mediated inhibition on NAFLD. Relevant biochemical parameters (lipid accumulation, extent of oxidative stress and release of inflammation cytokines) in oleic acid (OA)-induced HepG2 cells that mimicked steatosis in vitro were measured and compared with the control. It was found that nuciferine and silenced-PASK (siRNA PASK) both inhibited triglyceride (TG) accumulation and was effective in decreasing fatty acid (FFAs). The content of total antioxidant capacity (T-AOC) and superoxide dismutase (SOD) were increased respectively by nuciferine and siRNA PASK without increase in glutathione (GSH). Malondialdehyde (MDA) was decreased respectively by nuciferine and siRNA PASK. In addition, nuciferine decreased TNF-a, IL-6 and IL-8 as well as the siRNA PASK group. IL-10 was increased by nuciferine and siRNA PASK respectively. Further investigation revealed that nuciferine and siRNA PASK could respectively regulate the expression of target genes involved in lipogenesis and inflammation, suggesting that nuciferine may be a potential therapeutic treatment for NAFLD. Furthermore, the modulated effect of nuciferine on (OA)-induced HepG2 cells lipogenesis and inflammation, which was accompanied with PASK inhibition, was also consistent with siRNA PASK, implying that PASK might play a role in nuciferine-mediated regulation on NAFLD
- …